US News

Novartis Weighs Sale or Spinoff of Generic Drug Unit Sandoz

The unit has proven a drag on Novartis’s growth, its separation would be the final step toward the Swiss drug giant focusing solely on innovative drugs.

Jump To The Original Source

Facebook Comments

Check Also

As global costs soar, Japan’s ‘shrinkflation’ gets harder to swallow

Published by Reuters By Kantaro Komiya and Daniel ...

Archives